Literature DB >> 26209026

Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations.

Khalid Al-Baimani1, Amy Bazzarelli2, Mark Clemons3, Susan J Robertson4, Christina Addison5, Angel Arnaout6.   

Abstract

Pleomorphic lobular carcinoma is an uncommon form of breast cancer and a subtype of invasive lobular carcinoma. It has unique histopathologic features that translate to a more aggressive phenotype with an associated poor prognosis. Unlike classical invasive lobular carcinoma, it can lose estrogen and progesterone receptor expression and demonstrate HER-2/neu amplification. It remains to be determined, however, whether the pleomorphic histology independently predicts a worse outcome or whether other known associated negative prognostic factors such as larger tumor size, increased metastatic disease, and associated worse molecular subtypes commonly present in pleomorphic carcinoma account for the poor prognosis. Here we present an updated review of the unique pathologic and clinical features of pleomorphic lobular carcinoma needed to guide management for women with this subtype of cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Diagnosis; Histopathology; Invasive lobular cancer; Management; Pathogenesis; Pleomorphic

Mesh:

Year:  2015        PMID: 26209026     DOI: 10.1016/j.clbc.2015.06.010

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  11 in total

1.  IRS2 mutations linked to invasion in pleomorphic invasive lobular carcinoma.

Authors:  Sha Zhu; B Marie Ward; Jun Yu; Asia N Matthew-Onabanjo; Jenny Janusis; Chung-Cheng Hsieh; Keith Tomaszewicz; Lloyd Hutchinson; Lihua Julie Zhu; Dina Kandil; Leslie M Shaw
Journal:  JCI Insight       Date:  2018-04-19

2.  Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.

Authors:  Yu Zhang; Xiulan Luo; Min Chen; Libo Yang; Ting Lei; Tianjie Pu; Bing Wei; Hong Bu; Zhang Zhang
Journal:  Breast Cancer Res Treat       Date:  2022-06-06       Impact factor: 4.872

3.  Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.

Authors:  Rita A Mukhtar; Gregor Krings; Yunn-Yi Chen; Matina E Mamounas; Kelly Fahrner-Scott; Jasmine Wong; Michael Alvarado; Cheryl Ewing; Laura J Esserman; Hope Rugo
Journal:  Breast Cancer Res Treat       Date:  2020-04-02       Impact factor: 4.872

Review 4.  Linking DNA Damage and Hormone Signaling Pathways in Cancer.

Authors:  Matthew J Schiewer; Karen E Knudsen
Journal:  Trends Endocrinol Metab       Date:  2016-03-01       Impact factor: 12.015

5.  Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review.

Authors:  Mayumi Akaki; Akira Ishihara; Kentaro Nagai; Hidekazu Naono; Kenichi Taguchi; Hidetaka Yamamoto; Hiroyuki Tanaka; Hiroaki Kataoka
Journal:  Head Neck Pathol       Date:  2020-06-02

Review 6.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

7.  Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.

Authors:  Alicia Okines; Tazia Irfan; Bernice Asare; Kabir Mohammed; Peter Osin; Ashutosh Nerurkar; Ian E Smith; Marina Parton; Alistair Ring; Stephen Johnston; Nicholas C Turner
Journal:  Breast Cancer Res Treat       Date:  2022-02-04       Impact factor: 4.872

8.  Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.

Authors:  Mohammed F K Ibrahim; John Hilton; Christina Addison; Susan Robertson; Joel Werier; Sasha Mazzarello; Lisa Vandermeer; Carmel Jacobs; Mark Clemons
Journal:  J Bone Oncol       Date:  2016-07-07       Impact factor: 4.072

9.  Pancreatic metastasis from invasive pleomorphic lobular carcinoma of the breast: a rare case report.

Authors:  Xiangjie Sun; Ke Zuo; Dan Huang; Baohua Yu; Yufan Cheng; Wentao Yang
Journal:  Diagn Pathol       Date:  2017-07-11       Impact factor: 2.644

10.  Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy.

Authors:  Jennifer Zeng; Marcia Edelweiss; Dara S Ross; Bin Xu; Tracy-Ann Moo; Edi Brogi; Timothy M D'Alfonso
Journal:  Arch Pathol Lab Med       Date:  2021-06-01       Impact factor: 5.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.